In human cells, only a small proportion of the information written in genes is used to produce proteins. How does the cell ...
The firm will study its autologous cell therapy alone and in combination with Eisai's Lenvima in patients with hepatitis B-driven hepatocellular carcinoma.
Acceptance follows resolution of third-party fill/finish manufacturing issuesFDA decision expected by July 10, 2025 TARRYTOWN, N.Y., Feb. 11, ...
Background Early-life inflammation has long been recognised as a key pathophysiological process in the evolution of cystic ...